{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:02:48Z","timestamp":1787241768511,"version":"build-2736575974"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01200-4","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T03:10:01Z","timestamp":1748574601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["50 years of harm reduction in Europe: high time for transformation"],"prefix":"10.1186","volume":"22","author":[{"given":"Iga","family":"Jeziorska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Peter","family":"Kools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"2","key":"1200_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2006.11.006","volume":"18","author":"SR Friedman","year":"2007","unstructured":"Friedman SR, De Jong W, Rossi D, Touz\u00e9 G, Rockwell R, Des Jarlais DC, et al. Harm reduction theory: users\u2019 culture, micro-social Indigenous harm reduction, and the self-organization and outside-organizing of users\u2019 groups. Int J Drug Policy. 2007;18(2):107\u201317.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1200_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1086\/SHAD22020243","volume":"22","author":"G Blok","year":"2008","unstructured":"Blok G. Pampering needle freaks or caring for chronic addicts?? Early debates on harm reduction in Amsterdam, 1972\u201382. Soc Hist Alcohol Drugs. 2008;22(2):243\u201361.","journal-title":"Soc Hist Alcohol Drugs"},{"issue":"6","key":"1200_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/0306-4603(96)00042-1","volume":"21","author":"GA Marlatt","year":"1996","unstructured":"Marlatt GA. Harm reduction: come as you are. Addict Behav. 1996;21(6):779\u201388.","journal-title":"Addict Behav"},{"key":"1200_CR4","unstructured":"Harm Reduction International. Global State of Harm Reduction 2022. [Internet]. London: Harm Reduction International. 2022 [cited 2024 Jul 26]. Available from: https:\/\/hri.global\/wp-content\/uploads\/2022\/11\/HRI_GSHR-2022_Full-Report_Final.pdf"},{"key":"1200_CR5","unstructured":"Daan, van der Gouwe. Bob Diender, Nadine Van Gelder, Anouk de Gee. Recente inzichten in harm reduction voorzieningen in Nederland. Trimbos-instituut; 2022."},{"key":"1200_CR6","unstructured":"Jellinek [Internet]. 2023 [cited 2024 Jul 26]. Drug testing in the Netherlands: Why and how does it work? Available from: https:\/\/www.jellinek.nl\/vraag-antwoord\/why-do-they-test-drugs-the-netherlands-and-how-does-it-work\/"},{"key":"1200_CR7","unstructured":"Medicines Evaluation Board in the Netherlands. Public Assessment Report of the Medicines Evaluation Board in the Netherlands. Naloxon HCL-hameln 0.4\u00a0mg\/ml, solution for injection Hameln Pharma Plus GmbH, Germany [Internet]. Medicines Evaluation Board in the Netherlands; 2009 Sep [cited 2025 Feb 23] p. 11. Available from: https:\/\/www.geneesmiddeleninformatiebank.nl\/pars\/h28360.pdf"},{"issue":"2","key":"1200_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugpo.2010.01.004","volume":"21","author":"JR Ashton","year":"2010","unstructured":"Ashton JR, Seymour H. Public health and the origins of the Mersey model of harm reduction. Int J Drug Policy. 2010;21(2):94\u20136.","journal-title":"Int J Drug Policy"},{"issue":"S2","key":"1200_CR9","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.2105\/AJPH.2022.306790","volume":"112","author":"M Jauffret-Roustide","year":"2022","unstructured":"Jauffret-Roustide M, Houborg E, Southwell M, Chronopoulou D, Granier JM, Frank VA, et al. Different paths and potentials to harm reduction in different welfare States: drug consumption rooms in the united Kingdom, Denmark, and France. Am J Public Health. 2022;112(S2):S99\u2013103.","journal-title":"Am J Public Health"},{"key":"1200_CR10","doi-asserted-by":"publisher","first-page":"103670","DOI":"10.1016\/j.drugpo.2022.103670","volume":"104","author":"GW Shorter","year":"2022","unstructured":"Shorter GW, Harris M, McAuley A, Trayner KM, Stevens A. The united Kingdom\u2019s first unsanctioned overdose prevention site; A proof-of-concept evaluation. Int J Drug Policy. 2022;104:103670.","journal-title":"Int J Drug Policy"},{"key":"1200_CR11","first-page":"47","volume-title":"From the mountaintops: what the world can learn from drug policy change in Switzerland","author":"J Csete","year":"2010","unstructured":"Csete J. From the mountaintops: what the world can learn from drug policy change in Switzerland. New York, NY: Open Society Foundations; 2010. p. 47."},{"key":"1200_CR12","unstructured":"Wolf M, Herzig M. Inside Switzerland\u2019s Radical Drug Policy Innovation [Internet]. Stanford Social Innovation Review. 2019 [cited 2024 Aug 4]. Available from: https:\/\/ssir.org\/articles\/entry\/inside_switzerlands_radical_drug_policy_innovation"},{"issue":"1","key":"1200_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12954-022-00699-1","volume":"19","author":"M Bosch-Ar\u00eds","year":"2022","unstructured":"Bosch-Ar\u00eds M, Gasulla L, De Gispert T, Segura L, Colom J. The impact of the COVID-19 pandemic on harm reduction services in Catalonia: the experience of people who use drugs and harm reduction professionals. Harm Reduct J. 2022;19(1):118.","journal-title":"Harm Reduct J"},{"key":"1200_CR14","unstructured":"Infographic. Location and number of drug consumption facilities throughout Europe| www.euda.europa.eu [Internet]. [cited 2025 Feb 28]. Available from: https:\/\/www.euda.europa.eu\/media-library\/infographic-location-and-number-drug-consumption-room-facilities-throughout-europe_en"},{"key":"1200_CR15","volume-title":"The Swedish drug control policy. An in-depth review and analysis","author":"T van Boekhout","year":"1997","unstructured":"van Boekhout T. The Swedish drug control policy. An in-depth review and analysis. Amsterdam: Uitgeverij Jan Mets\/CEDRO; 1997."},{"key":"1200_CR16","unstructured":"Kroon RQ. & A \/ Wim Kok: The Dutch View on Drugs. The New York Times [Internet]. 1996 [cited 2024 Jul 26]; Available from: https:\/\/www.nytimes.com\/1996\/04\/09\/IHT-q-a-wim-kok-the-dutch-view-on-drugs.html"},{"key":"1200_CR17","unstructured":"Haque MS. New Public Management: Origins, Dimensions and Critical Implications. In: Public Administration and Public Policy - Volume 1 [Internet]. Encyclopedia of Life Support Systems (EOLSS). Oxford, UK: UNESCO-EOLSS; [cited 2024 Aug 9]. Available from: http:\/\/www.eolss.net\/ebooklib\/ebookcontents\/e1-34-themecontents.pdf"},{"issue":"1","key":"1200_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1096-7494(01)00041-1","volume":"4","author":"G Gruening","year":"2001","unstructured":"Gruening G. Origin and theoretical basis of new public management. Int Public Manag J. 2001;4(1):1\u201325.","journal-title":"Int Public Manag J"},{"key":"1200_CR19","unstructured":"European Drug EUDA. Report 2024: Trends and Developments [Internet]. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2024 [cited 2024 Jul 18]. Available from: https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2024_en"},{"issue":"9068","key":"1200_CR20","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/S0140-6736(96)11380-5","volume":"349","author":"SF Hurley","year":"1997","unstructured":"Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997;349(9068):1797\u2013800.","journal-title":"Lancet"},{"issue":"5\u20136","key":"1200_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0955-3959(03)00133-6","volume":"14","author":"M MacDonald","year":"2003","unstructured":"MacDonald M, Law M, Kaldor J, Hales J, Dore J. Effectiveness of needle and syringe programmes for preventing HIV transmission. Int J Drug Policy. 2003;14(5\u20136):353\u20137.","journal-title":"Int J Drug Policy"},{"issue":"Suppl 1","key":"1200_CR22","first-page":"75","volume":"113","author":"D Vlahov","year":"1998","unstructured":"Vlahov D, Junge B. The role of needle exchange programs in HIV prevention. Public Health Rep. 1998;113(Suppl 1):75\u201380.","journal-title":"Public Health Rep"},{"issue":"6\u20137","key":"1200_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/10826080600669579","volume":"41","author":"A Wodak","year":"2006","unstructured":"Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Subst Use Misuse. 2006;41(6\u20137):777\u2013813.","journal-title":"Subst Use Misuse"},{"issue":"9","key":"1200_CR24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo","year":"2021","unstructured":"Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. Association of opioid agonist treatment with All-Cause mortality and specific causes of death among people with opioid dependence: A systematic review and Meta-analysis. JAMA Psychiatry. 2021;78(9):979.","journal-title":"JAMA Psychiatry"},{"key":"1200_CR25","doi-asserted-by":"crossref","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;j1550.","DOI":"10.1136\/bmj.j1550"},{"key":"1200_CR26","doi-asserted-by":"publisher","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Drugs and Alcohol Group, editor. Cochrane Database Syst Rev [Internet]. 2009 Jul 8 [cited 2024 Jul 27]; Available from: https:\/\/doi.org\/10.1002\/14651858.CD002209.pub2","DOI":"10.1002\/14651858.CD002209.pub2"},{"issue":"1","key":"1200_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.drugpo.2009.03.004","volume":"21","author":"MA Andresen","year":"2010","unstructured":"Andresen MA, Boyd N. A cost-benefit and cost-effectiveness analysis of Vancouver\u2019s supervised injection facility. Int J Drug Policy. 2010;21(1):70\u20136.","journal-title":"Int J Drug Policy"},{"key":"1200_CR28","unstructured":"Belackova V, Salmon AM, Schatz E, Jauncey M. Online census of Drug Consumption Rooms (DCRs) as a setting to address HCV: current practice and future capacity. 2018."},{"issue":"5","key":"1200_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11904-017-0363-y","volume":"14","author":"MC Kennedy","year":"2017","unstructured":"Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV\/AIDS Rep. 2017;14(5):161\u201383.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"1200_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/pubmed\/fdl090","volume":"29","author":"JA Stoltz","year":"2007","unstructured":"Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, et al. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health. 2007;29(1):35\u20139.","journal-title":"J Public Health"},{"key":"1200_CR31","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.2147\/RMHP.S244720","volume":"14","author":"V Tran","year":"2021","unstructured":"Tran V, Reid SE, Roxburgh A, Day CA. Assessing drug consumption rooms and longer term (5 Year) impacts on community and clients. Risk Manag Healthc Policy. 2021;14:4639\u201347.","journal-title":"Risk Manag Healthc Policy"},{"key":"1200_CR32","unstructured":"European Union Drugs EMCDDA. Agency. 2018 [cited 2024 Aug 6]. Drug consumption rooms: an overview of provision and evidence (Perspectives on drugs). Available from: https:\/\/www.euda.europa.eu\/publications\/pods\/drug-consumption-rooms_en"},{"key":"1200_CR33","doi-asserted-by":"crossref","unstructured":"Stevens A, Keemink JR, Shirley-Beavan S, Khadjesari Z, Artenie A, Vickerman P et al. Overdose prevention centres as spaces of safety, trust and inclusion: A causal pathway based on a realist review. Drug Alcohol Rev. 2024;dar.13908.","DOI":"10.1111\/dar.13908"},{"key":"1200_CR34","unstructured":"EMCDDA. Alternatives to punishment for drug-using offenders [Internet]. Luxembourg: Publications Office of the European Union; 2015 [cited 2024 Aug 10]. (EMCDDA papers). Available from: https:\/\/data.europa.eu\/doi\/10.2810\/60310"},{"key":"1200_CR35","unstructured":"Council of the European Union. Council conclusions on promoting the use of alternatives to coercive sanctions for drug using offenders. [Internet]. 6931\/18 Mar 8. 2018. Available from: https:\/\/www.euda.europa.eu\/document-library\/council-conclusions-promoting-use-alternatives-coercive-sanctions-drug-using-offenders_en"},{"key":"1200_CR36","unstructured":"EMCDDA. Prison and drugs in Europe: current and future challenges. [Internet]. LU: Publications Office; 2022 [cited 2023 Dec 23]. Available from: https:\/\/data.europa.eu\/doi\/10.2810\/420042"},{"key":"1200_CR37","unstructured":"Federal Bureau of Prisons [Internet]. 2024 [cited 2024 Aug 10]. BOP Statistics: Inmate Offenses. Available from: https:\/\/www.bop.gov\/about\/statistics\/statistics_inmate_offenses.jsp"},{"key":"1200_CR38","unstructured":"World Prison Brief. World Prison Brief. 2024 [cited 2024 Aug 10]. United States of America. Available from: https:\/\/www.prisonstudies.org\/country\/united-states-america#"},{"key":"1200_CR39","unstructured":"Wagner P, Sawyer W, Prison Policy I. 2024 [cited 2024 Aug 10]. Mass Incarceration: The Whole Pie 2024. Available from: https:\/\/www.prisonpolicy.org\/reports\/pie2024.html"},{"key":"1200_CR40","unstructured":"Council of the European Union. EU, Drugs Strategy. (2005\u20132012) [Internet]. 15074\/04 Nov 22, 2004. Available from: https:\/\/www.euda.europa.eu\/document-library\/eu-drugs-strategy-2005-2012_en"},{"key":"1200_CR41","unstructured":"Council of the European Union. EU Drugs Action Plan for 2009\u20132012 [Internet]. 2008\/C 326\/09 Dec 20, 2008. Available from: https:\/\/www.euda.europa.eu\/document-library\/eu-drugs-action-plan-2009-2012_en"},{"key":"1200_CR42","unstructured":"Council of the European Union. EU Drugs Strategy 2013\u20132020 [Internet]. 2012\/C 402\/01 Dec 29. 2012. Available from: https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:C:2012:402:0001:0010:en:PDF"},{"key":"1200_CR43","unstructured":"Cots Fern\u00e1ndezAIDPC. 2023 [cited 2024 Jul 18]. A new EU drug policy is coming. Will it be reactionary? Available from: https:\/\/idpc.net\/blog\/2023\/10\/a-new-eu-drug-policy-is-coming-will-it-be-reactionary"},{"key":"1200_CR44","unstructured":"CSFD. Civil Society Forum on Drugs\u2019 response on the EU Drug Agenda. 2020\u20132025. [Internet]. 2020 [cited 2024 Aug 4]. Available from: http:\/\/www.civilsocietyforumondrugs.eu\/wp-content\/uploads\/2020\/10\/CSFD_Response_to_EU_DrugAgenda.pdf"},{"key":"1200_CR45","unstructured":"Harm Reduction International. Global State of Harm Reduction 2024 [Internet]. London: Harm Reduction International. 2024 [cited 2025 Feb 28]. Available from: https:\/\/hri.global\/wp-content\/uploads\/2024\/10\/GSR24_full-document_12.12.24_B.pdf"},{"key":"1200_CR46","unstructured":"European Drug EUDA. Report 2024: Harm reduction [Internet]. 2024 [cited 2024 Oct 5]. Available from: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2024\/harm-reduction_en"},{"key":"1200_CR47","unstructured":"EUDA. Statistical Bulletin 2024: Health and social responses - needle and syringe programmes [Internet]. 2023 [cited 2024 Aug 16]. Available from: https:\/\/www.euda.europa.eu\/data\/stats2024\/hsr_en#displayTable:HSR-4-1"},{"key":"1200_CR48","unstructured":"EUDA. Statistical Bulletin 2024: Problem drug use - injecting [Internet]. 2024 [cited 2024 Aug 16]. Available from: https:\/\/www.euda.europa.eu\/data\/stats2024\/pdu_en#displayTable:PDU-1-2"},{"issue":"1","key":"1200_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12954-020-00428-6","volume":"17","author":"M Miovsk\u00fd","year":"2020","unstructured":"Miovsk\u00fd M, Mikl\u00edkov\u00e1 S, Mrav\u010d\u00edk V, Grund JP, \u010cern\u00edkov\u00e1 T. Understanding the crisis in harm reduction funding in central and Eastern Europe. Harm Reduct J. 2020;17(1):83.","journal-title":"Harm Reduct J"},{"key":"1200_CR50","unstructured":"Cook C. Harm reduction investment in the European Union: Current spending, challenges and successes [Internet]. London: Harm Reduction International; 2017 [cited 2024 Jul 18]. Available from: https:\/\/hri.global\/wp-content\/uploads\/2023\/02\/HRWreportApril2017_web_1-2.pdf"},{"key":"1200_CR51","unstructured":"Campenhout CV, Rossignol C, Levaux C. EU sees drug crime as threatening as terrorism, says must fight on European level. Reuters [Internet]. 2023 Feb 8 [cited 2024 Aug 6]; Available from: https:\/\/www.reuters.com\/world\/europe\/eu-sees-drug-crime-threatening-terrorism-says-must-fight-european-level-2023-02-07\/"},{"key":"1200_CR52","unstructured":"European Commission. Communication from the Commission to the European Parliament and the Council on the EU roadmap to fight drug trafficking and organised crime [Internet]. COM(2023) 641 Oct 18, 2023. Available from: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A52023DC0641"},{"key":"1200_CR53","unstructured":"European Commission. Fighting child sexual abuse, drugs and illegal firearms [Internet]. 2020 [cited 2024 Aug 12]. Available from: https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_1380"},{"key":"1200_CR54","unstructured":"EUDA. Drug seizures in the European Union \u2013 quantity of drugs seized, indexed trends [Internet]. 2024 [cited 2024 Aug 12]. Available from: https:\/\/www.euda.europa.eu\/media-library\/edr24\/infographic-drug-seizures-european-union-quantity-drugs-seized-indexed-trends_en"},{"key":"1200_CR55","unstructured":"EUDA. Drug seizures in the European Union \u2013 number of drug seizures, indexed trends (2012\u2009=\u2009100) [Internet]. 2024 [cited 2024 Aug 12]. Available from: https:\/\/www.euda.europa.eu\/media-library\/infographic-drug-seizures-european-union-%E2%80%93-number-drug-seizures-indexed-trends-2012-100-updated-june-2024_en"},{"key":"1200_CR56","unstructured":"UNODC. World Drug Report 2023 [Internet]. Vienna: UNODC; 2023. Available from: https:\/\/www.unodc.org\/res\/WDR-2023\/Special_Points_WDR2023_web_DP.pdf"},{"key":"1200_CR57","volume-title":"Speed limits. Harm reduction for people who use stimulants","author":"R Rigoni","year":"2018","unstructured":"Rigoni R, Breeksema J, Woods S. Speed limits. Harm reduction for people who use stimulants. Amsterdam: MAINline; 2018."},{"key":"1200_CR58","unstructured":"UNODC. Afghanistan opium survey 2023. Cultivation and production after the ban: effects and implications. [Internet]. UNODC; 2023. (UNODC Research brief). Available from: https:\/\/www.unodc.org\/documents\/crop-monitoring\/Afghanistan\/Afghanistan_opium_survey_2023.pdf"},{"key":"1200_CR59","unstructured":"United Nations.: Office on Drugs and Crime [Internet]. [cited 2025 Mar 5]. Afghanistan: opium cultivation increased by 19 per cent in second year of drugs ban, according to UNODC. Available from: http:\/\/www.unodc.org\/unodc\/en\/press\/releases\/2024\/October\/afghanistan_-opium-cultivation-increased-by-19-per-cent-in-second-year-of-drugs-ban--according-to-unodc.html"},{"issue":"8","key":"1200_CR60","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/add.16420","volume":"119","author":"PN Griffiths","year":"2024","unstructured":"Griffiths PN, Seyler T, De Morais JM, Mounteney JE, Sedefov RS. Opioid problems are changing in Europe with worrying signals that synthetic opioids May play a more significant role in the future. Addiction. 2024;119(8):1334\u20136.","journal-title":"Addiction"},{"key":"1200_CR61","unstructured":"Blanchet T, Chancel L, Gethin A. How Unequal Is Europe? Evidence from Distributional National Accounts, 1980\u20132017 [Internet]. World Inequality Lab; 2019 [cited 2024 Aug 12]. Report No.: WID.world WORKING PAPER N\u00b0 2019\/06. Available from: https:\/\/wid.world\/document\/bcg2019-full-paper\/"},{"key":"1200_CR62","unstructured":"Eurostat. At-risk-of-poverty rate by poverty threshold, age and sex [Internet]. 2024 [cited 2024 Aug 16]. Available from: https:\/\/ec.europa.eu\/eurostat\/databrowser\/view\/ILC_LI02__custom_5706066\/default\/table?lang=en"},{"key":"1200_CR63","unstructured":"Amand-Eeckhout L, European Parliamentary Research Service. Mental health in the EU [Internet]. 2023 [cited 2024 Aug 12]. Available from: https:\/\/www.europarl.europa.eu\/RegData\/etudes\/BRIE\/2023\/751416\/EPRS_BRI(2023)751416_EN.pdf"},{"key":"1200_CR64","unstructured":"European Values EVS. Study. 2018 [cited 2024 Aug 16]. European Values Study: Society. Available from: https:\/\/europeanvaluesstudy.eu\/about-evs\/research-topics\/society\/"},{"key":"1200_CR65","unstructured":"Rogialli A, Perez Gayo R, Schiffer K, Shaw G. Creating Safer Consumption Spaces in Europe: Evolving Contexts and Implications for Policy. [Internet]. Amsterdam: Correlation \u2013 European Harm Reduction Network; 2023 [cited 2024 Aug 19]. Available from: https:\/\/correlation-net.org\/wp-content\/uploads\/2024\/07\/2024_Creating-Safer-Consumption-Spaces-in-Europe_Policy-Advocacy-Brief.pdf"},{"key":"1200_CR66","unstructured":"Jeziorska I. Implementation of the EU Action Plan on Drugs 2017\u20132020: The civil society perspective. Report of the Civil Society Forum on Drugs [Internet]. Brussels: Civil Society Forum on Drugs; 2022 [cited 2024 Jul 24]. Available from: http:\/\/www.civilsocietyforumondrugs.eu\/wp-content\/uploads\/2022\/05\/220529_APimplementation_report.pdf"},{"key":"1200_CR67","unstructured":"Rogialli A, Jeziorska I, Schiffer K, Vas B. Harm Reduction Advocacy in Europe: Needs, Challenges and Lessons Learnt. Policy and Advocacy Report. [Internet]. Amsterdam: Correlation - European Harm Reduction Network; 2024 [cited 2024 Aug 18]. Available from: https:\/\/correlation-net.org\/wp-content\/uploads\/2024\/02\/240229_Policy-and-Advocacy-Report_Final.pdf"},{"issue":"1","key":"1200_CR68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/00914509241231821","volume":"51","author":"NE Kruis","year":"2024","unstructured":"Kruis NE, Kaynak \u00d6, Whipple C, Saylor E, Kensinger W. Addiction frameworks, social stigma, and NIMBY syndrome: examining barriers to responding to the opioid crisis. Contemp Drug Probl. 2024;51(1):3\u201324.","journal-title":"Contemp Drug Probl"},{"key":"1200_CR69","unstructured":"Gerster J, Global News. 2019 [cited 2024 Aug 18]. \u2018Not in My Backyard\u2019: How NIMBYism impacts access to vital support services. Available from: https:\/\/globalnews.ca\/news\/5698658\/addictions-nimby\/"},{"key":"1200_CR70","first-page":"42","volume-title":"Abolitionism: towards a Non-Repressive approach to crime","author":"N Christie","year":"1986","unstructured":"Christie N. Suitable enemies. In: Bianchi H, van Swaaningen R, editors. Abolitionism: towards a Non-Repressive approach to crime. Amsterdam: Free University; 1986. pp. 42\u201354."},{"key":"1200_CR71","unstructured":"de Jong C. EenVandaag. 2019 [cited 2024 Aug 19]. CDA en ChristenUnie willen drugsgebruikers vervolgen om criminaliteit aan te pakken: \u2018Kennelijk willen ze niet luisteren, dan moeten ze maar voelen\u2019. Available from: https:\/\/eenvandaag.avrotros.nl\/item\/cda-en-cu-willen-druggebruikers-vervolgen-om-criminaliteit-aan-te-pakken-kennelijk-willen-ze-niet\/"},{"key":"1200_CR72","unstructured":"UK Home Office. GOV.UK. 2022 [cited 2025 Mar 6]. From harm to hope: A 10-year drugs plan to cut crime and save lives. Available from: https:\/\/www.gov.uk\/government\/publications\/from-harm-to-hope-a-10-year-drugs-plan-to-cut-crime-and-save-lives"},{"key":"1200_CR73","volume-title":"Certain, tough: new consequences for drug possession","author":"Swift","year":"2022","unstructured":"Swift. Certain, tough: new consequences for drug possession. London: Dandy Booksellers Ltd; 2022."},{"key":"1200_CR74","doi-asserted-by":"publisher","first-page":"103844","DOI":"10.1016\/j.drugpo.2022.103844","volume":"109","author":"A Stevens","year":"2022","unstructured":"Stevens A. New prospects for harm reduction in the UK? A commentary on the new UK drug strategy. Int J Drug Policy. 2022;109:103844.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1200_CR75","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13011-021-00394-7","volume":"16","author":"X R\u00eago","year":"2021","unstructured":"R\u00eago X, Oliveira MJ, Lameira C, Cruz OS. 20 Years of Portuguese drug policy - developments, challenges and the quest for human rights. Subst Abuse Treat Prev Policy. 2021;16(1):59.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"1200_CR76","doi-asserted-by":"crossref","unstructured":"Hemerijck A. Two or three waves of welfare state transformation? In: Morel N, Palier B, Palme J, editors. Towards a Social Investment Welfare State? [Internet]. Policy Press; 2011 [cited 2024 Aug 16]. pp. 33\u201360. Available from: https:\/\/bristoluniversitypressdigital.com\/view\/book\/9781847429261\/ch002.xml","DOI":"10.46692\/9781847429261.002"},{"key":"1200_CR77","unstructured":"Blair T, Schroeder G, Europe. The Third Way\/Die Neue Mitte [Internet]. Johannesburg: Friedrich-Ebert-Stiftung South Africa Office; 1998 [cited 2024 Aug 19]. Report No.: Working Documents No.2. Available from: https:\/\/library.fes.de\/pdf-files\/bueros\/suedafrika\/02828.pdf"},{"key":"1200_CR78","volume-title":"The three worlds of welfare capitalism","author":"G Esping-Andersen","year":"1990","unstructured":"Esping-Andersen G. The three worlds of welfare capitalism. Princeton, New Jersey: Princeton University Press; 1990."},{"key":"1200_CR79","volume-title":"The reduction of drug-related harm","author":"R Newcombe","year":"1992","unstructured":"Newcombe R. The reduction of drug-related harm. A conceptual framework for theory, practice and research. The reduction of drug-related harm. London; New York: Routledge; 1992."},{"issue":"3","key":"1200_CR80","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/09595239500185371","volume":"14","author":"E Single","year":"1995","unstructured":"Single E. Defining harm reduction. Drug Alcohol Rev. 1995;14(3):287\u201390.","journal-title":"Drug Alcohol Rev"},{"key":"1200_CR81","first-page":"290","volume-title":"Drug use for grown-ups: chasing liberty in the land of fear","author":"CL Hart","year":"2021","unstructured":"Hart CL. Drug use for grown-ups: chasing liberty in the land of fear. New York: Penguin; 2021. p. 290."},{"key":"1200_CR82","unstructured":"McSweeney K, James C, Lugo DA, Chagas R, Araujo FN, Benites GV et al. Revealing the missing link to Climate Justice: Drug Policy [Internet]. London: Health Poverty Action; 2023 [cited 2024 Aug 16]. Available from: https:\/\/www.healthpovertyaction.org\/wp-content\/uploads\/2023\/10\/REPORT-Revealing-the-Missing-Link-to-Climate-Justice-Drug-Policy.pdf"},{"issue":"1","key":"1200_CR83","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12954-021-00564-7","volume":"18","author":"C Daniels","year":"2021","unstructured":"Daniels C, Aluso A, Burke-Shyne N, Koram K, Rajagopalan S, Robinson I, et al. Decolonizing drug policy. Harm Reduct J. 2021;18(1):120.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1200_CR84","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1477370819887514","volume":"19","author":"A Stevens","year":"2022","unstructured":"Stevens A, Hughes CE, Hulme S, Cassidy R. Depenalization, diversion and decriminalization: A realist review and programme theory of alternatives to criminalization for simple drug possession. Eur J Criminol. 2022;19(1):29\u201354.","journal-title":"Eur J Criminol"},{"key":"1200_CR85","unstructured":"Santos JM, The Global Commission on Drug Policy. Ex-Colombia president Santos calls for overhaul of global drug policies [Internet]. 2021 [cited 2024 Aug 16]. Available from: https:\/\/www.globalcommissionondrugs.org\/ex-colombia-president-santos-calls-for-overhaul-of-global-drug-policies"},{"issue":"5","key":"1200_CR86","first-page":"507","volume":"19","author":"K Szott","year":"2015","unstructured":"Szott K. Contingencies of the will: uses of harm reduction and the disease model of addiction among health care practitioners. Health Interdiscip J Soc Study Health Illn Med. 2015;19(5):507\u201322.","journal-title":"Health Interdiscip J Soc Study Health Illn Med"},{"key":"1200_CR87","volume-title":"Evaluating the brain disease model of addiction","year":"2022","unstructured":"Heather N, Field M, Moss AC, Satel S, editors. Evaluating the brain disease model of addiction. London: Routledge; 2022."},{"issue":"1","key":"1200_CR88","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12954-024-01132-5","volume":"21","author":"A Ritter","year":"2024","unstructured":"Ritter A, Barrett L. People who use drugs and the right to health. Harm Reduct J. 2024;21(1):215.","journal-title":"Harm Reduct J"},{"key":"1200_CR89","volume-title":"Regulating paradise. The local origins of harm reduction in the Netherlands","author":"A Nuijten","year":"2024","unstructured":"Nuijten A. Regulating paradise. The local origins of harm reduction in the Netherlands. [Amsterdam]: University of Amsterdam; 2024."},{"issue":"1","key":"1200_CR90","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/09627251.2012.721980","volume":"89","author":"L Wacquant","year":"2012","unstructured":"Wacquant L. The punitive regulation of poverty in the neoliberal age. Crim Justice Matters. 2012;89(1):38\u201340.","journal-title":"Crim Justice Matters"},{"key":"1200_CR91","unstructured":"Harm Reduction International. Making the investment case. Cost-effectiveness evidence for harm reduction. [Internet]. London: Harm Reduction International. 2020. Available from: https:\/\/hri.global\/wp-content\/uploads\/2020\/04\/COST_EFFECTIVENESS_BRIEFING-APRIL-2020-ENG.pdf"},{"key":"1200_CR92","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.drugpo.2014.11.007","volume":"26","author":"DP Wilson","year":"2015","unstructured":"Wilson DP, Donald B, Shattock AJ, Wilson D, Fraser-Hurt N. The cost-effectiveness of harm reduction. Int J Drug Policy. 2015;26:S5\u201311.","journal-title":"Int J Drug Policy"},{"issue":"11","key":"1200_CR93","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.2105\/AJPH.2018.304649","volume":"108","author":"JK Vallance","year":"2018","unstructured":"Vallance JK, Gardiner PA, Lynch BM, D\u2019Silva A, Boyle T, Taylor LM, et al. Evaluating the evidence on sitting, smoking, and health: is sitting really the new smoking?? Am J Public Health. 2018;108(11):1478\u201382.","journal-title":"Am J Public Health"},{"key":"1200_CR94","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2147\/PRBM.S324235","volume":"14","author":"KS Woo","year":"2021","unstructured":"Woo KS, Bong SH, Choi TY, Kim JW. Mental health, smartphone use type, and screen time among adolescents in South Korea. Psychol Res Behav Manag. 2021;14:1419\u201328.","journal-title":"Psychol Res Behav Manag"},{"key":"1200_CR95","unstructured":"Lanier J. Ten arguments for deleting your social media accounts right now. First edition. New York: Henry Holt and Company; 2018. 146 p."},{"issue":"4","key":"1200_CR96","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1017\/S0029665117000805","volume":"76","author":"MR Yeomans","year":"2017","unstructured":"Yeomans MR. Adverse effects of consuming high fat\u2013sugar diets on cognition: implications for Understanding obesity. Proc Nutr Soc. 2017;76(4):455\u201365.","journal-title":"Proc Nutr Soc"},{"key":"1200_CR97","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4159\/9780674239241","volume-title":"The age of addiction: how bad habits became big business","author":"DT Courtwright","year":"2019","unstructured":"Courtwright DT. The age of addiction: how bad habits became big business. Cambridge, Massachusetts: Belknap Press of Harvard University; 2019. p. 325."},{"issue":"1","key":"1200_CR98","first-page":"259","volume":"87","author":"KD Brownell","year":"2009","unstructured":"Brownell KD, Warner KE. The perils of ignoring history: big tobacco played dirty and millions died. How Similar Is Big Food? Milbank Q. 2009;87(1):259\u201394.","journal-title":"How Similar Is Big Food? Milbank Q"},{"issue":"19","key":"1200_CR99","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1111\/bph.13813","volume":"174","author":"LC d\u2019Angelo","year":"2017","unstructured":"d\u2019Angelo LC, Savulich G, Sahakian BJ. Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure. Br J Pharmacol. 2017;174(19):3257\u201367.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1200_CR100","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/13676260600983668","volume":"10","author":"GP Hunt","year":"2007","unstructured":"Hunt GP, Evans K, Kares F. Drug use and meanings of risk and pleasure. J Youth Stud. 2007;10(1):73\u201396.","journal-title":"J Youth Stud"},{"issue":"4","key":"1200_CR101","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/09687630701726841","volume":"15","author":"GP Hunt","year":"2008","unstructured":"Hunt GP, Evans K. The great unmentionable\u2019: exploring the pleasures and benefits of ecstasy from the perspectives of drug users. Drugs Educ Prev Policy. 2008;15(4):329\u201349.","journal-title":"Drugs Educ Prev Policy"},{"issue":"5","key":"1200_CR102","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.drugpo.2007.07.003","volume":"19","author":"C Duff","year":"2008","unstructured":"Duff C. The pleasure in context. Int J Drug Policy. 2008;19(5):384\u201392.","journal-title":"Int J Drug Policy"},{"key":"1200_CR103","doi-asserted-by":"crossref","unstructured":"Bear D, Hosker-Field A, Westall K, D\u2019Alessio H, Cresswell M. Harm reduction isn\u2019t enough: introducing the concept of mindful consumption and benefit maximization (MCBM). Int J Drug Policy. 2024;104514.","DOI":"10.1016\/j.drugpo.2024.104514"},{"issue":"1","key":"1200_CR104","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12954-017-0145-2","volume":"14","author":"LM Boucher","year":"2017","unstructured":"Boucher LM, Marshall Z, Martin A, Larose-H\u00e9bert K, Flynn JV, Lalonde C, et al. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs. Harm Reduct J. 2017;14(1):18.","journal-title":"Harm Reduct J"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01200-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01200-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01200-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:04:10Z","timestamp":1748577850000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01200-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1200"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01200-4","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"24 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare to give consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}